About Us | Contact Us | Expert Panel
Infectious Diseases Hub

Single dose of genetically-altered broadly-neutralizing antibodies SHIV-protective in monkeys

0
HIV / AIDS
Immunology, Pre-clinical Trials
Last updated:

Authors: Martha Powell, Future Science Group

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID; MD, USA) have reported two genetically-modified broadly-neutralizing antibodies (bNAbs) elicit long-term protection against a HIV-like virus in rhesus macaques.
To view restricted content, please:
Register FREE
Share:

Leave A Comment